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The purpose of this study was to characterize the effects of medications and systemic diseases on major salivary 
gland flow rates. Unstimulated and 2% citrate-stimulated parotid and submandibular salivas were collected from 293 subjects of 
the oral physiology component of thle Baltimore Longitudinal Study of Aging. The influence of the number of medications and 
diseases on salivary flow rates was determined by separate one-way ANOVA tests. There was an overall decrease in both 
parotid and submandibular flow rates with increasing numbers of medications and systemic diseases. However, this was 
significant (p < 0.05) only for unstimulated submandibular flow rates (with increasing numbers of systemic diseases) and 
stimulated submandibular flow rates (with increasing numbers of systemic diseases and medications). Unstimulated flow rates 
rapidly approached zero with increasing numbers of medications and diseases. These results suggest that the submandibular 
gland may be more sensitive to physiologic permutations than the parotid gland. In addition, individuals being treated for 
multiple systemic diseases and taking numerous medications may be more susceptible to salivary hypofunction. (ORAL SURC ORAL 
MED ORAL PATHOL 1993;76:301-6) 
Decreased salivation is a common side effect of drug 
use.l An estimated 120 million people each year ob- 
tain prescription medications.2 Seventy-five percent 
of office visits to general medical practitioners and in- 
ternists are associated with the continuation or initi- 
ation of a prescribed medication.3 The prevalence of 
xerostomia or the subjective complaint of dry mouth 
has been reported to be 29% in an adult population.4 
However, many subjects in this study4 were taking 
medications, and this may have been the cause of their 
xerostomia.5 Indeed, several studies have associated 
medications with decreased salivary flo~.~-” .Johnson 
et al.’ l examined a population of chronically ill, long- 
term hospitalized elderly patients and found 44% of 
them complained of xerostomia and 43% actually had 
low stimulated parotid flow. These studies suggest 
that lboth medication use and systemic disease may 
influence salivary function. 
Previous studies of medicated persons have exam- 
ined only whole salivary or parotid flow rates. How- 
ever, recent studies12-14 that examined parotid and 
submandibular/sublingual function separately sug- 
gest the submandibular/sublingual glands are more 
susceptible to the influence of systemic disease than 
the parotid gland. The purpose of this study was to 
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characterize unstimulated and 2% citrate-stimu- 
lated parotid and submandibular/sublingual salivary 
flow rates in the presence of medications and systemic 
diseases in a well-characterized, ambulatory popula- 
tion. 
MATERIAL AND METHODS 
Study population 
The study population included 293 volunteer par- 
ticipants in the (oral physiology component15 of the 
Baltimore Longitudinal Study of Aging.16 These per- 
sons were community-dwelling, ambulatory, white, 
and of middle socioeconomic class. Participants were 
examined by a physician, and diagnoses were based on 
clinical and laboratory results.17 Only subjects with 
well-controlled medical conditions were included in 
this study. Prescription medication usage was well 
documented in this population. Patients brought cur- 
rent medications to the clinic and completed a self- 
reported history that was reviewed by the examiner. 
Vitamins, aspirin, and topically applied dermatologic 
preparations were not included in the total medication 
count. 
Saliva collection 
Subjects refrained from eating, drinking, and oral 
hygiene procedures for a minimum of 90 minutes be- 
fore salivary collection. Samples were collected be- 
tween 8:30 AM and 11 AM by a single investigator 
(J.A.S.). Unstimulated (resting) samples were col- 
lected initially for 5 minutes. This was followed by 
stimulation with 2% citrate applied to the dorsolateral 
surfaces of the tongue for 5 seconds at 30-second in- 
tervals.18 After a. 2-minute equilibration period, stim- 
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*Based on lowest and highest 10th percentile values from a control popuiation.23 
iTotal number of medications taken. Note that there is no one taking 5 or 6 medications. 
$Persons taking one or more medications are more likely to have a low (versus high) flow rate; chi-square, p < 0.05. 
gHigh salivary flow as determined from the highest 10th percentile of a control population. 
//Low salivary flow as determined from the lowest 10th percentile of a control population. 
p() is the percentage of persons with a low or high salivary flow rate. 
ulated parotid secretions were collected for 2 minutes. 
Unstimulated and stimulated parotid saliva was col- 
lected from a single salivary gland with the use of a 
modified Carlson-Crittenden cup as described previ- 
o~sly.‘~, 2o Submandibular/sublingual saliva was col- 
lected from the orifice of Wharton’s duct with a mi- 
cropipette attached to gentle suction as described 
previously. 21 After collection, the volume of saliva 
was determined gravimetrically, assuming a specific 
gravity of 1 .O. Submandibular saliva, as defined in this 
article, represents a combined submandibular and 
sublingual secretion because of the frequent common 
exit of the gland ducts.22 
RESULTS 
Statistical analysis 
Men (N = 169) and women (N = 124) between 
the ages of 19 to 93 years (mean age = 60.4 years, 
median age = 64 years) comprised the study popula- 
tion One hundred seventy-one persons were taking no 
prescription medications, and 122 persons were tak- 
ing one or more medications (Table I). One hundred 
eighty-two persons were not being treated for any 
medical disease, and 111 persons were being treated 
for one or more diseases (Table 11). Unstimulated and 
stimulated major gland flow rates of unmedicated 
persons who were not being treated for any systemic 
diseases were not statistically different between men 
and women. Therefore the gender values were corn- 
bined for all analyses. 
Subjects were categorized according to the number Unstimulated and stimulated major salivary gland 
of prescription medications that they were taking and flow rates progressively diminish with increasing 
the number of diseases for which they were currently numbers of prescription medications (Fig. 1). How- 
being treated. The influence of the number of medi- ever, this pattern was statistically significant only for 
cations and the number of systemic diseases on each stimulated submandibular flow rates for 0 to 7 med- 
of the four major salivary flow rates was determined ications (p = 0.002, Fig. 1) and from 0 to 4 medica- 
by one-way ANOVA tests. In addition, individual tions (p = 0.001, Fig. 1). The distribution of subjects 
salivary gland flow rates were identified as being ei- with salivary flow rates categorized as being either 
ther low or high from previously established control low or high according to the number of prescription 
population standards using the lowest or highest 10th medications is provided in Table I. With increasing 
percentiles. 23 The frequency of subjects with low or numbers of drugs, the prevalence of subjects with low 
high salivary gland flow rates for each of the four flow flow rates, according to control populations stan- 
rates was analyzed by a x2 test. Data were analyzed dards,23 increased. Conversely, the prevalence of sub- 
with the use of RSl software (BBN software prod- jects with high flow rates diminished with increasing 
ucts, Cambridge, Mass.). Significance was selected at numbers of drugs. Chi-square tests were performed 
the p < 0.05 level. between subjects who take no medications and per- 
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Table II. Prevale:nce of high or low salivary gland flow rates according to the number of systemic diseases* 
Unstimulatedf Stimulated Unstimulatedf Stimulatedf 
Number of parotid parotid submandibular submandibular 
medical N 
conditions Total High$ Lo@ High Low High Low High Low 
*Based on lowest and highest 10th percentile values from a control population.23 
~Persons being treated for one or more systemic diseases are more likely to have a low (versus high) flow rate; chi-square, p < 0.05. 
$High salivary flow rate as determined from the highest 10th percentile of a control population. 
SLOW salivary flow rate as determined from the lowest 10th percentile of a control population. 
]I() is the percentage of persons with a low or high salivary flow rate. 
sons who take one or more medications. Subjects who 
take one or more medications were significantly more 
likely to have low unstimulated parotid (p = 0.047), 
unstimulated submandibular (p = O.OOl), and stimu- 
lated submandibular (JJ = 0.002) flow rates. For ex- 
ample, approximately one quarter or more of these 
persons had low unstimulated parotid and unstimu- 
lated and stimulated submandibular salivary flow 
rates compared with approximately 10% of subjects 
not taking any prescription medications (Table I). 
According to Fig. 2, major salivary gland flow rates 
decline with increasing numbers of diseases. This was 
statistically significant for unstimulated submandib- 
ular (p = 0.04) and stimulated submandibular (p = 
0.001) flow rates for 0 to 4 diseases and from 0 to 3 
diseases (JJ = 0.03 and p = 0.001, respectively) but 
not for the parotid secretions. The distribution of 
subjects with salivary flow rates categorized as being 
either low or high according to the number of diseases 
for which subjlects were being treated is provided in 
Table II. With increasing numbers of diseases, the 
prevalence of subjects with high flow rates decreased 
and the prevalence of subjects with low flow rates in- 
creased. Chi-square tests between persons being 
treated for one or more systemic diseases versus no 
diseases revealed that subjects with one or more sys- 
temic diseases were statistically more likely to have 
low unstimulated parotid (JJ = 0.015), unstimulated 
submandibular (p = O.OOl), and stimulated subman- 
dibular (p = 0.001) flow rates. More than one quar- 
ter of the persons with one or m.ore systemic diseases 
had low unstimulated parotid and unstimulated and 
stimulated submandibular flow rates, compared with 
approximately 10% of subjects not being treated for 
any systemic diseases (Table II). 
DISCUSSION 
This study examined individual parotid and sub- 
mandibular salivary gland flow rates in a population 
of community-dwelling, volunteer participants taking 
prescription medications and having well-controlled 
systemic disease. The results of this study suggest that 
although there is a generalized decrease in parotid 
and submandibular flow rates in the presence of med- 
ications and systemic diseases, the submandibular 
gland is affected to a greater extent then the parotid 
gland. These conclusions extend previous findings 
that demonstrated a trend of decreasing whole sali- 
vary and parotid flow rates in the presence of diseases 
and medications in elderly institutionalized popula- 
tions 1, g-11,24 
Subjects taking one or more medications or being 
treated for one or more systemic diseases were not at 
greater risk of having low stimulated parotid flow 
rates compared with their healthy counterparts (Ta- 
bles I and 11). In contrast, subjects taking one or more 
medications or being treated for one or more diseases 
were more likely to have a low unstimulated and 
stimulated submandibular salivary flow rate (Tables 
I and II). Only the submandibular flow rates demon- 
strated a statistically significant decline in the pres- 
ence of increasing medications and systemic diseases. 
One caveat to this observation is that the number of 
persons who take several medications or have numer- 
ous systemic diseases in this study is small. However, 
three studies that examined major salivary flow rates 
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Fig. 1. Regression of mean ( i sem) (A) nnstimulated and 
(B) 2% citrate-stimulated parotid and submandibular flow 
rates according to prescription medications that subjects 
were taking. Total number of persons taking 0, 1) 2,3,4, and 
7 medications was 171, 49, 43, 21, 7, and 2 respectively, 
Qne-way ANOVA results were statistically significant for 
stimulated submandibular flow rates (p = 0.002). Statisti- 
cally significant results are denoted with an *. 
of persons with one specific disease also found that the 
submandibular gland is more susceptible to the effects 
of systemic disease. 12-14 Two percent citrate-stimu- 
lated submandibular flow rates were observed to be 
below normal in 87.5% of patients with SjjBgren’s 
syndrome while stimulated parotid flow was de- 
creased in only 54.7%. I2 In unmedicated patients with 
Alzheimer’s disease, unstimulated and stimulated 
submandibular gland flow rates were markedly di- 
minished with no alteration in parotid secretions.13 A 
longitudinal evaluation of major salivary gland func- 
tion in HIV-1 infected patients found that the sub- 
mandibular gland manifested alterations in function 
earlier than the parotid gland.14 Therefore the find- 
ings in this study corroborate studies that examined 
the effect of a specific disease on salivary flow sug- 
gesting that thesubmandibular gland may be preferen- 
tially vulnerable to exogenous influences. 
LlNSTlMULATED FL.0 
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Fig. 2. Regression of mean (L sem) (A) unstimulated and 
(B) 2% citrate-stimulated parotid and submandibular flow 
rates according to systemic diseases that subjects were be- 
ing treated for. Total number of persons with 0, 1, 2, 3, and 
4 systemic diseases was 182, 7 1, 3 I, 8, and 1 respectively. 
One-way ANOVA results were statistically significant for 
unstimulated submandibular (p = 0.04) and stimulated 
submandibular flow rates (p = 0.001). Statistically signif- 
icant results are denoted with an *. 
The significance of this finding is that the subman- 
dibular gland is a major contributor to total salivary 
production. The proportional contribution of the sub- 
mandibular, parotid, and sublingual glands under 
resting or unstimulated conditions has been estimated 
to be 69%, 26%, and 5%, respectively.25 The contri- 
bution of the minor glands has been determined to be 
from 0 to 8%. 25, 26 This article considers submandib- 
ular and sublingual secretions as a single measure- 
ment. Therefore in the most severe case of total loss 
of unstimulated submandibular/sublingual flow, a 
person may lose up to 74% of their total unstimulated 
salivary production. 
Many histologic, anatomic, neurologic, and physi- 
ologic differences exist between the submandibular 
and parotid gland in health, in aging, and in the pres- 
ence of systemic diseases. 27 To date there is no suit- 
able explanation for this apparent increased suscepti- 
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bility (of the submandibular gland secretory function 
to medication and disease. Collection of whole or pa- 
rotid saliva is limited in that it does not provide com- 
prehensive functional information about all major 
glands. This study demonstrates the need for more 
information regarding the submandibular gland. 
Unstimulated salivary flow rates rapidly ap- 
proached zero with increasing numbers of medica- 
tions and diseases (Figs. 1 and 2) In addition, those 
persons taking one or more medications or having one 
or more diseases were more likely to have unstimu- 
lated parotid and unstimulated submandibular flow 
rates lhat were in the lowest 10th percentile than in 
the highest 10th percentile of salivary flow rates (Ta- 
bles I and II) This is an important observation because 
unstimulated salivary flow is a m.easure of the amount 
of saliva that is constantly secreted to protect and to 
lubricate the oral cavity, whereas stimulated salivary 
flow is a measure of the functional capacity of the 
gland. Unstimulated secretions may be of greater 
signifi.cance to person’s perception of dryness as well 
as their ability to maintain homeostasis.5 Therefore 
the results from these analyses exhibit a pattern sug- 
gesting that persons being treated for numerous sys- 
temic diseases and/or taking multiple medications 
are likely to have little or no unstimulated salivary 
output. As a result, these persons are not receiving the 
full protection provided by saliva and are placed at 
increased risk for developing the numerous complica- 
tions of salivary gland hypofunction.28 
A limitation of this study is that it was not possible 
to truly separate the effects of medications and 
diseases on salivary flow. Many subjects had a 
systemic disease and were taking one or more pre- 
scription medications. Therefore it is unknown if the 
salivary effects seen in this study are due to the effects 
of medication, the effects of diseases, or a combina- 
tion of both. Unfortunately, it was not possible to dis- 
tinguish effects of individual medications or systemic 
diseases on major salivary gland flow rates because of 
the srnall sample size of persons in these groups. 
In this study, age and gender were not considered 
factors that would significantly influence major sali- 
vary gland flow rates. Major salivary gland flow rates 
appear to be gender independent,18> 20, 27, 2g and pa- 
rotid salivary flow rates remain stable with age in 
healthy persons. 20, 2g, 3o However, the effect of healthy 
aging on submandibular function is not as clear-cut. 
Pederson et aL31 found an age-associated decrease in 
submandibular flow rates. Alternatively, Tylenda et 
al.,‘* with the use of salivary collection techniques 
similar to those used in this study, found no changes 
in submandibular gland flow rates across the human 
life span. 
The results of t.his study demonstrate that with in- 
creasing numbers of diseases and medications, there 
is a greater likelihood that major salivary gland out- 
put will decrease. Unstimulated salivary flow rates 
rapidly approach zero in the presence of increasing 
medications and diseases. In addition, the subman- 
dibular gland may be more susceptible to external or 
physiologic permutations than the parotid gland. This 
study utilized only subjects taking prescription med- 
ications who hadl well-controlled disease. One may 
speculate that subjects who take multiple medications 
with uncontrolled disease may exhibit even greater 
salivary dysfunction. It will be necessary in future in- 
vestigations to define which and how specific drugs 
and diseases have a deleterious effect on salivary 
gland function as well as the effect of the interaction 
of numerous medications and medical conditions on 
secretory function. Ultimately, it will be necessary to 
completely understand and diagnose salivary dys- 
function so as to direct studies aimed at the treatment 
of xerostomia. 
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